Abstract:Targeted therapies of melanoma are of urgent need considering the resistance of this aggressive type of cancer to chemotherapeutics. The voltage-dependent anion channel 1 (VDAC1)–hexokinase-II (HK-II) complex is an emerging target for novel anticancer therapies based on induced mitochondria-mediated apoptosis. The low cell membrane permeability of the anticancer 12-mer peptide N-Ter (RDVFTKGYGFGL) derived from the N-terminal fragment of the VDAC1 protein impedes the intracellular targeting. Here, novel multiblock VDAC1-derived cationic amphiphilic peptides (referred to as Pal-N-Ter-TAT, pFL-N-Ter-TAT, and Pal-pFL-N-Ter-TAT) are designed with a self-assembly propensity and cell-penetrating properties. The created multiblock amphiphilic peptides of partial α-helical conformations form nanoparticles of ellipsoid-like shapes and are characterized by enhanced cellular uptake. The amphiphilic peptides can target mitochondria and dissociate the VDAC1–HK-II complex at the outer mitochondrial membrane, which result in mitochondria-mediated apoptosis. The latter is associated with decrease of the mitochondrial membrane potential, cytochrome c release, and changes of the expression levels of the apoptotic proteins in A375 melanoma cells. Importantly, the mitochondrial VDAC1-derived amphiphilic peptides have a comparable IC50 value for melanoma cells to a small-molecule drug, sorafenib, which has been previously used in clinical trials for melanoma. These results demonstrate the potential of the designed peptide constructs for efficient melanoma inhibition.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acsami.1c04385.Summary of IC50 values for cell death induction by the peptides of Pal-N-Ter-TAT and Pal-pFL-N-Ter-TAT in various cancer cell lines; A375 cell uptake of dansylglycine-labeled peptides by flow cytometry; and confocal microscopy study of intracellular localization of peptides (PDF)This article has not yet been cited by other publications.

Mitochondrial Targeting Domain Homologs Induce Necrotic Cell Death Via Mitochondrial and Endoplasmic Reticulum Disruption

Artificial Peptide-Protein Necrosomes Promote Cell Death

Development of apoptosis-inducing polypeptide via simultaneous mitochondrial membrane disruption and Ca2+ delivery

Mitochondrial Mechanisms of Necroptosis in Liver Diseases

Mitochondria as multifaceted regulators of cell death

Targeting Mitochondrial Degradation by Chimeric Autophagy-Tethering Compounds.

Necrocide 1 mediates necrotic cell death and immunogenic response in human cancer cells

Differential membrane binding of α/β-peptide foldamers: implications for cellular delivery and mitochondrial targeting

The TAT-RasGAP317-326 anti-cancer peptide can kill in a caspase-, apoptosis-, and necroptosis-independent manner

Targeting Mitochondria Degradation by Chimeric Autophagy-Tethering Compounds

Self-assembly of Mitochondria-Specific Peptide Amphiphiles Amplifying Lung Cancer Cell Death Through Targeting the VDAC1-hexokinase-II Complex.

Mts1 (S100A4) and Its Peptide Demonstrate Cytotoxic Activity in Complex with Tag7 (PGLYRP1) Peptide

Mitochondrial Membrane Permeabilization in Cell Death

Mitochondria-associated programmed cell death as a therapeutic target for age-related disease

Role of C-terminal domain of Mycobacterium tuberculosis PE6 (Rv0335c) protein in host mitochondrial stress and macrophage apoptosis

Targeting Cellular Apoptotic Pathway with Peptides from Marine Organisms

Targeted Protein Degradation in the Mitochondrial Matrix and Its Application to Chemical Control of Mitochondrial Morphology

Mitochondrial Voltage-Dependent Anion Channel 1–Hexokinase-II Complex-Targeted Strategy for Melanoma Inhibition Using Designed Multiblock Peptide Amphiphiles

Membrane-bound TNF Mediates Microtubule-Targeting Chemotherapeutics-Induced Cancer Cytolysis Via Juxtacrine Inter-Cancer-cell Death Signaling

Downregulation of Mitochondrial Fusion Protein Expression Affords Protection from Canonical Necroptosis in H9c2 Cardiomyoblasts